|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Non-operating income: | |||||
| Interest and other income, net | |||||
| Loss from change in fair value of derivative liabilities | |||||
| Embedded derivative | |||||
| Warrant derivative | |||||
| Total non-operating income (expense), net | |||||
| Net loss | |||||
| Other comprehensive income (loss): | |||||
| Net unrealized gain (loss) on marketable debt securities | |||||
| Comprehensive loss | |||||
| Net loss per common share - basic (in dollars per share) | |||||
| Net loss per common share - diluted (in dollars per share) | |||||
| Weighted average shares outstanding - basic (in shares) | |||||
| Weighted average shares outstanding - diluted (in shares) | |||||
Loading...